Genus plc

LSE GNS.L

Genus plc Net Income for the year ending June 30, 2024: USD 10.00 M

Genus plc Net Income is USD 10.00 M for the year ending June 30, 2024, a -76.34% change year over year. Net income is the total profit earned by a company after deducting all expenses, including taxes and non-controlling interest.

Genus plc Net Income for the year ending June 30, 2023 was USD 42.27 M, a -15.12% change year over year.
Genus plc Net Income for the year ending June 30, 2022 was USD 49.80 M, a -23.86% change year over year.
Genus plc Net Income for the year ending June 30, 2021 was USD 65.41 M, a 49.43% change year over year.
Genus plc Net Income for the year ending June 30, 2020 was USD 43.77 M, a 342.03% change year over year.

Key data

Date	Net Income	EPS (Diluted)	Shares (Diluted, Weighted)	Net Income Margin

LSE: GNS.L

Genus plc

CEO	Mr. Jorgen Kokke
IPO Date	July 6, 2000
Location	United Kingdom
Headquarters	Matrix House
Employees	3,500
Sector	Health Care
Industries Biotechnology Agriculture

Description

Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells sows, boars, and semen to breed pigs with various characteristics for pork production under the PIC brand. The company also sells bull semen and embryos to breed calves with various characteristics for milk and beef production under the ABS, Genus, and Bovec brands. In addition, it offers semen sexing, in reproductive, and other technical services to farmers. Genus plc has a strategic collaboration with Beijing Capital Agribusiness Co. Ltd to pursue the porcine reproductive respiratory syndrome virus resistant regulatory and development work in China. The company was incorporated in 1994 and is based in Basingstoke, the United Kingdom.

Key trends

Past 5 years